Success in the dispute with BASF and the Citi study drive Bayer

Relief for Bayer shareholders: Contrary to fears that have recently flared up again in connection with the sale of the seed business, the pharmaceutical and agrochemical group does not have to pay any damages to the chemical group BASFto count. Bayer shares were at the top of the Dax on Fridayby 3.75 percent to 53.62 euros.

Michael Cooper

Learn More →